Filed before 2025Filed 17 March 2020
Primmune Therapeutics, Inc. raised $1.1M
Primmune Therapeutics, Inc., a pharmaceuticals company based in San Diego, CA, raised $1.1M in a new round, according to a filing dated 17 March 2020.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 17 March 2020
- Round
- Round
- Amount sold
- $1.1M
- Offering size
- $4M
- Investors so far
- 19
- Based in
- San Diego, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 12% of the 1,744 tracked raises with an amount filed in 2020, and than 10% of the 40 in pharmaceuticals.
Primmune Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 6 Nov 2020 | New filing | $13M | Another raise |
| 17 Mar 2020 | New filing | $2.5M | Another raise |
| 17 Mar 2020 | New filing | $2M | Another raise |
| 17 Mar 2020 | New filing | $1.1M | This raise |
More with Valence Advantage Life Sciences on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.